Chemical Structure : HF13141-H5
货号: PC-26237Not For Human Use, Lab Use Only.
HF13141-H5 is a potent, selective inhibitor of γ-Glutamyl carboxylase (GGCX) with IC50 of 240 nM-1 uM in cell-based assays, inhibits γ-carboxylation of vitamin K-dependent clotting factors (VKDCFs) and shows anticoagulant effect.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
HF13141-H5 is a potent, selective inhibitor of γ-Glutamyl carboxylase (GGCX) with IC50 of 240 nM-1 uM in cell-based assays, inhibits γ-carboxylation of vitamin K-dependent clotting factors (VKDCFs) and shows anticoagulant effect.
HF13141-H5 specifically inhibits GGCX activity without affecting vitamin K epoxide reductase (VKOR) function.
HF13141-H5 inhibited vitamin K epoxidation in a dose dependent manner, completely abolishing epoxidation activity at 20 uM in in vitro vitamin K epoxidation activity assay.
HF13141-H5 competitively inhibits GGCX by occupying the KH2 substrate-binding pocket.
HF13141-H5 mimics the binding of reduced vitamin K.
HF13141-H5 maintained full inhibitory potency against VKOR variants associated with warfarin resistance and demonstrated robust anticoagulant activity in a zebrafish laser-induced endothelial injury model.
| 分子量 | 415.45 | |
| 分子式 | C24H21N3O4 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Guomin Shen, et al. Blood Adv. 2025 Dec 22:bloodadvances.2025018776.
2. Patent CN113831293 A 2021-12-24.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright